Brown & Brown (BRO) Q4 2025 earnings review
Inorganic Surge Masks Organic Contraction
Brown & Brown closed FY25 with a massive topline beat, growing revenue 35.7% YoY to $1.6B, driven entirely by the Accession acquisition. However, the core business engine sputtered significantly: Organic Revenue reversed from +13.8% a year ago (and +3.5% in Q3) to a contraction of 2.8% in Q4. While Adjusted EPS grew 8.1% to $0.93, GAAP earnings fell 19% as integration costs weighed on results. Management achieved flat adjusted margins (32.9%) despite the revenue surge, indicating that scale efficiencies from the mega-deal have yet to materialize.
🐂 Bull Case
The integration of Accession (RSC) is significantly boosting topline scale, adding ~$423M in revenue YoY. If integration costs stabilize, the 35% revenue growth provides a massive base for future earnings leverage.
Despite the GAAP earnings hit, operating cash flow for FY25 remained robust at $1.45B, up significantly from $1.17B in FY24, supporting continued M&A and dividend growth.
🐻 Bear Case
Organic revenue turned negative (-2.8%) for the first time in recent cycles. This misses the 'stable' guidance implied in Q3 and suggests severe headwinds in the Specialty/Retail segments beyond simple comp issues.
Adjusted EBITDAC margin was flat YoY (32.9%) despite a 35% revenue jump. Usually, this level of inorganic growth should drive operating leverage; its absence suggests high underlying expense inflation or lower-margin acquired revenue.
⚖️ Verdict: 🔴
Bearish. While the headline revenue growth looks impressive, it is purely purchased. The reversal of organic growth into negative territory (-2.8%) is a major red flag that calls into question the health of the legacy business amidst the integration of a massive acquisition.
Key Themes
Organic Revenue Reverses to Negative
Organic revenue growth has deteriorated rapidly: from 13.8% in 24Q4 to -2.8% in 25Q4. In the Q3 call, management guided for Retail to be 'similar' to Q3 (2.7%) and Specialty to be down mid-single digits. A consolidated -2.8% result implies either a steeper-than-expected collapse in Specialty Distribution or a surprise contraction in Retail. This indicates potential market share loss or faster-than-anticipated rate softening.
Accession Deal Dominates Topline
The Accession acquisition is the sole driver of the 35.7% revenue beat. Total commissions and fees jumped to $1.58B from $1.16B. However, the cost of this growth is evident in the P&L: Amortization expense nearly tripled to $116M (vs $48M YoY) and Interest Expense doubled to $100M (vs $46M YoY), dragging down GAAP profitability.
Quality of Earnings Deterioration
There is a widening gap between GAAP and Non-GAAP reality. GAAP Diluted EPS fell 19.2% to $0.59, while Adjusted EPS rose 8.1% to $0.93. The bridge includes substantial add-backs for 'Acquisition/Integration Costs' ($27M in Q4) and 'Change in estimated acquisition earn-out payables.' The reliance on adjustments to show growth is increasing.
Cash Flow Generation Remains Strong
Despite the P&L noise, cash generation is accelerating. FY25 Operating Cash Flow reached $1.45B, up 23.5% from $1.17B in FY24. The company utilized this cash to pay down $600M on its revolving credit facility and repurchase $100M in treasury stock during the year, signaling financial flexibility remains intact.
Other KPIs
Stable. The margin was exactly flat YoY (32.9% vs 32.9%). This is a disappointment given the significant revenue scaling (+35%), suggesting that integration costs or lower margins within the Accession book are offsetting synergies.
Accelerating. Interest expense more than doubled from $46M in 24Q4, reflecting the debt raised to fund the Accession deal. This $54M quarterly increase is a significant headwind to GAAP net income.
Decelerating. Dropped from 23.2% in 24Q4. The 320 bps decline highlights the true cost of the acquisition strategy (interest + amortization + integration costs) before 'Adjusted' metrics strip them out.
Guidance
Management did not provide specific FY26 numeric guidance in the earnings release text. In the absence of the earnings call transcript, we cannot confirm specific targets for Organic Growth or Margins for the upcoming fiscal year.
Key Questions
Organic Revenue Contraction Drivers
Organic revenue fell 2.8% this quarter. Was this decline driven solely by the anticipated difficult comps in the Specialty Distribution segment, or did the Retail segment also contract? What is the specific organic growth figure for Retail in Q4?
Margin Stagnation despite Scale
With revenue up 35% driven by Accession, why did Adjusted EBITDAC margin remain flat at 32.9%? When can investors expect the synergies from this acquisition to translate into meaningful margin expansion?
Interest Expense Trajectory
Interest expense more than doubled YoY to $100M in Q4. Is this the new quarterly run-rate, and what is the deleveraging plan for FY26 to mitigate this drag on GAAP earnings?
Acquisition/Integration Cost Timeline
Q4 included $27M in acquisition/integration costs. How long will these 'non-recurring' costs persist into FY26, and at what level?